AAR MEETING WORKING GROUP MEDICAL DEFENSE AGAINST BIO WAR

File: 120396_sep96_decls42_0003.txt
Page: 0003
Total Pages: 5

Subject: AAR MEETING WORKING GROUP MEDICAL DEFENSE AGAINST BIO WAR       

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5    

Document Number:          1

Folder SEQ  #:        172





                                                     UNCLASSIFIED


          on the prevention, diagnosis, and treatment of BW casuall
          Endemic disease threats will also be addressed in this
          document.

                   (5) (U) Exportable Training Package - Material
          prepared and packaged for distribution to the field on BV
          countermeasures: See response to item (4).

                   (6) (U) Use of a Protective Mask - Can an altei          e
          to the chemical protective mask be used to protect agains
          agents (e.g., dust mask with HEPA filter): Alternative
          respiratory protection is available on the market and cot
          used to protect against BW agents. The Navy representatj
          expressed interest in placing some of these respirators c
          their ships which would allow personnel (e.g., medical) t
          perform their mission.

                   (7)       Immunization Schedule for Anthrax and
          Pentavalent Toxoid - Challenge studies conducted by USAM          0
          evaluate the efficacy of only completing a Portion of the





                   (8)       Ability of Chemoprophylactic Agents - F,
          much of a variety of antibiotics are available or can be
          available to be used as chemoprophylactic agents: Ample
          supplies of doxycycline and ciprofloxacin are commerciall
          available and will be prepositioned in-theater

                   (9) (U) Use of Anthrax Vaccine by Allied Nation
          Are the British or any other allies currently using anthx
          vaccine: While there was no information available that a
          other nation was immunizing against anthrax, the British
          expressed an interest in immunizing their forces in-theat

                   (10)       Prioritization of Available Vaccines f
          Deploying Units: The Ad Hoc committee recommends that th
          CENTCOM Commander establish the prioritization of units t
 vaccine. As additional supplies of a          c
          vaccine are available, the Ad Hoc Committee recommends tb         L
          U.S. Forces in-theater receive the three doses of anthrax
          vaccine. However, given projected levels of vaccine, two          9
          should be given at 0 and 14 days, followed by a third dos
          28+ days as vaccine becomes available. Due to the liraite
          supply of the botulinum toxoid, only selected forces shou
          receive it.

                   (11)       Increasing Industrial Production of tb
          Vaccines - Can the suppliers of these vaccines increase t
          production schedule: USAIIRDC reported that
          anthrax vaccine were received by 31 August 1990 and addit
          shipments are expected by 16 September and 10 October 199
                                  t%rnnrz         UNCLASSIFIED

Document 5 f:/Week-36/BX003203/AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5/aar meeting working group medical defense agains:11089615093343
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5
Folder Seq # = 172
Subject = AAR MEETING WORKING GROUP MEDICAL DEFENSE AGAINS
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996